By Michele Maatouk
Date: Wednesday 14 Jan 2026
(Sharecast News) - Oxford Biomedica confirmed on Wednesday that it has received unsolicited takeover approaches from private equity firm EQT.
| Total Voting Rights | 02-Jan-2026 | ShareCast |
| Block Listing Return | 02-Jan-2026 | ShareCast |
| Oxford Biomedica acquires US viral vector facility | 07-Oct-2025 | ShareCast |
| Oxford Biomedica reiterates outlook as interim l... | 23-Sep-2025 | ShareCast |
| RBC Capital Markets raises target price on OXB | 26-Aug-2025 | ShareCast |
| Form 8.3 - Amendment | 23-Jan-2026 | 16:59 | RNS |
| Form 8.3 - Oxford Biomedica plc | 23-Jan-2026 | 16:36 | RNS |
| Form 8.3 - Oxford Biomedica plc | 23-Jan-2026 | 15:20 | RNS |
| Form 8.5 (EPT/RI)- Oxford Biomedica plc | 23-Jan-2026 | 09:36 | RNS |
| Form 8.5 (EPT/NON-RI)-Oxford Biomedica plc | 23-Jan-2026 | 08:39 | RNS |
| Need to know: Opec cuts forecast ... Tesco cuts ... | 16-Aug-2008 | Times |
| Need to know | 10-May-2008 | Times |
| DSG International may be losing its spark | 12-Feb-2008 | Telegraph |
| Oxford BioMedica clinches $690m licensing deal f... | 29-Mar-2007 | The Independent |
| Oxford Biomedica seals €518m deal with Sanofi ov... | 29-Mar-2007 | Times |
No recent information was found.
| Currency | UK Pounds |
| Share Price | 871.00p |
| Change Today | 18.00p |
| % Change | 2.11 % |
| 52 Week High | 913.00 |
| 52 Week Low | 232.50 |
| Volume | 192,299 |
| Shares Issued | 120.81m |
| Market Cap | £1,052.25m |
| Beta | 2.06 |
| RiskGrade | 125 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 5 |
| Buy | 2 |
| Neutral | 3 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 10 |

| No dividends found |
| Time | Volume / Share Price |
| 17:10 | 4,000 @ 871.00p |
| 16:35 | 1,130 @ 871.00p |
| 16:35 | 238 @ 871.00p |
| 16:35 | 31,008 @ 871.00p |
| 16:35 | 82 @ 871.00p |
| Chair | Roch Doliveux |
| CEO | Frank Mathias |
| CFO | Lucinda (Lucy) Crabtree |
You are here: research